Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis (original) (raw)

Nature volume 349, pages 612–614 (1991)Cite this article

Abstract

EPSTEiN-Barr virus (EBV), a human herpesvirus, establishes a persistent asymptomatic infection of the circulating B-lymphocyte pool1–3. The mechanism of virus persistence is not understood but, given the limited lifespan of most B cells in vivo, it seems most likely that EBV-infected cells must gain access to the long-lived memory B-cell pool. Here we show in an in vitro system that EBV, through expression of the full set of eight virus-coded 'latent' proteins, can protect human B cells from programmed cell death (apoptosis), the deletion mechanism which normally restricts entry into memory4. We have found that EBV-positive Burkitt's lym-phoma (BL) cell clones5 retaining the original tumour cell phenotype and expressing only one of the virus latent proteins, the nuclear antigen EBNA 1, are extremely sensitive to apoptosis; in this respect they resemble the tumour's normal cell of origin found in the germinal centres of lymphoid tissue. By contrast, isogenic BL cell clones which have activated expression of all eight EBV latent proteins are resistant to the induction of apoptosis. The EBV latent proteins should therefore be seen not just as activators of B-cell proliferation but, perhaps more importantly, as mediators of enhanced B-cell survival.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Nilsson, K., Klein, G., Henle, W. & Henle, G. Int. J. Cancer 8, 443–450 (1971).
    Article CAS Google Scholar
  2. Gratama, J. W. et al. Proc. natn. Acad. Sci. U.S.A. 85, 8693–8696 (1988).
    Article CAS ADS Google Scholar
  3. Yao, Q. Y., Ogan, P., Rowe, M., Wood, M. & Rickinson, A. B. Int. J. Cancer 43, 67–71 (1989).
    Article CAS Google Scholar
  4. Liu, Y-J. et al. Nature 342, 929–931 (1989).
    Article CAS ADS Google Scholar
  5. Gregory, C. D., Rowe, M. & Rickinson, A. B. J. gen. Virol. 71, 1481–1495 (1990).
    Article CAS Google Scholar
  6. Rowe, M. et al. Int. J. Cancer 35, 435–442 (1985).
    Article CAS Google Scholar
  7. Rooney, C. M. et al. J. natn. Cancer Inst. 77, 681–687 (1986).
    Article CAS Google Scholar
  8. Rowe, M. et al. EMBO J. 6, 2743–2751 (1987).
    Article CAS Google Scholar
  9. Wyllie, A. H. Int. Rev. Cytol. 68, 252–305 (1981).
    Google Scholar
  10. Wyllie, A. H. Nature 284, 555–556 (1980).
    Article CAS ADS Google Scholar
  11. McConkey, D. J., Orrenius, S. & Jondal, M. Immun. Today 11, 120–121 (1990).
    Article CAS Google Scholar
  12. Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J. & Owen, J. J. T. Nature 337, 181–184 (1989).
    Article CAS ADS Google Scholar
  13. Wyllie, A. H., Morris, R. G., Smith, A. L. & Dunlop, D. J. Path. 142, 67–77 (1984).
    Article CAS Google Scholar
  14. Calender, A. et al. Proc. natn. Acad. Sci. U.S.A. 84, 8060–8064 (1987).
    Article CAS ADS Google Scholar
  15. Berard, C. W. in Burkitt's Lymphoma: A Human Cancer Model IARC Scient. Pub. No. 60 (eds Lenoir, G., O'Connor, G. & Olweny, C. L. M.) 31–35 (IARC, Lyon, 1985).
    Google Scholar
  16. Mann, R. B. et al. New Engl. J. Med. 295, 685–691 (1976).
    Article CAS Google Scholar
  17. Gregory, C. D. et al. J. Immun. 139, 313–318 (1987).
    CAS PubMed Google Scholar
  18. MacLennan, I. C. M., Liu, Y-J., Oldfield, S., Zhang, J. & Lane, P. J. L. Curr. Topics microbiol. immun. 159, 37–63 (1990).
    CAS Google Scholar
  19. Pennell, C. A. & Scott, D. W. Eur. J. Immun. 16, 1577–1581 (1986).
    Article CAS Google Scholar
  20. Hasbold, J. & Klaus, G. G. B. Eur. J. Immun. 20, 1685–1690 (1990).
    Article CAS Google Scholar
  21. Yates, J., Warren, N., Reisman, D. & Sugden, B. Proc. natn. Acad. Sci. U.S.A. 81, 3806–3810 (1984).
    Article CAS ADS Google Scholar
  22. McConkey, D. J., Hartzell, P., Duddy, S. K., Hakansson, H. & Orrenius, S. Science 242, 256–258 (1989).
    Article ADS Google Scholar
  23. Arends, M. J., Morris, R. G. & Wyllie, A. H. Am. J. Path. 136, 593–608 (1990).
    CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, University of Birmingham Medical School, Birmingham, B15 2TT, UK
    Christopher D. Gregory & John Gordon
  2. Department of Cancer Studies, University of Birmingham Medical School, Birmingham, B15 2TT, UK
    Sheila Henderson & Alan B. Rickinson
  3. Department of Anatomy, University of Birmingham Medical School, Birmingham, B15 2TT, UK
    Christopher A. Smith & Gwyn T. Williams
  4. Pharmaceutical Sciences Institute, University of Aston, Birmingham, B4 7ET, UK
    Caroline Dive

Authors

  1. Christopher D. Gregory
    You can also search for this author inPubMed Google Scholar
  2. Caroline Dive
    You can also search for this author inPubMed Google Scholar
  3. Sheila Henderson
    You can also search for this author inPubMed Google Scholar
  4. Christopher A. Smith
    You can also search for this author inPubMed Google Scholar
  5. Gwyn T. Williams
    You can also search for this author inPubMed Google Scholar
  6. John Gordon
    You can also search for this author inPubMed Google Scholar
  7. Alan B. Rickinson
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Gregory, C., Dive, C., Henderson, S. et al. Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis.Nature 349, 612–614 (1991). https://doi.org/10.1038/349612a0

Download citation

This article is cited by